Aflatoxin Literature: Respiratory System

Share:Share on FacebookTweet about this on TwitterPin on Pinterest



Lee RJ, Workman AD, Carey RM, Chen B, Rosen PL, Doghramji L, Adappa ND, Palmer JN, Kennedy DW, Cohen NA. Fungal Aflatoxins Reduce Respiratory Mucosal Ciliary Function. Sci Rep. 2016 Sep 14;6:33221. PMID: 27623953

Shen H, Liu C, Shao P, Yi L, Wang Y, Mills Ko E, Tian Z, Zhao X, Wang J, Xing L, Zhang X. Enhanced phenotypic alterations of alveolar type II cells in response to Aflatoxin G1 -induced lung inflammation. J Cell Physiol. 2015 Jun;230(6):1199-211. PMID: 25336278

Zhang Z, Lu H, Huan F, Meghan C, Yang X, Wang Y, Wang X, Wang X, Wang SL. Cytochrome P450 2A13 mediates the neoplastic transformation of human bronchial epithelial cells at a low concentration of aflatoxin B1. Int J Cancer. 2014 Apr 1;134(7):1539-48. PMID: 24114584

Ali S, Malik A, Shahid M, Bhargava R. Pulmonary aspergillosis and aflatoxins in chronic lung diseases. Mycopathologia. 2013 Oct;176(3-4):287-94. PMID: 23948964

Zhang Z, Yang X, Wang Y, Wang X, Lu H, Zhang X, Xiao X, Li S, Wang X, Wang SL. Cytochrome P450 2A13 is an efficient enzyme in metabolic activation of aflatoxin G1 in human bronchial epithelial cells. Arch Toxicol. 2013 Sep;87(9):1697-707. PMID: 23907605

Zhang Fang, An Yun-fang F., Zhao Chang-qing Q.. [Preliminary study on Aspergillus fumigates-induced IKKα controlled maspin protein expression in respiratory epithelial cells of rats]. Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery. 2013;48:48–53.

Ali Sana, Malik Abida, Shahid Mohd, Bhargava Rakesh. Pulmonary aspergillosis and aflatoxins in chronic lung diseases. Mycopathologia. 2013;176:287–294.

Yang Xuejiao, Zhang Zhan, Wang Xichen, et al. Cytochrome P450 2A13 enhances the sensitivity of human bronchial epithelial cells to aflatoxin B1-induced DNA damage. Toxicology and applied pharmacology. 2013;270:114–121.

Zhang Zhan, Lu Huiyuan, Huan Fei, et al. Cytochrome P450 2A13 mediates the neoplastic transformation of human bronchial epithelial cells at a low concentration of aflatoxin B1. International journal of cancer. Journal international du cancer. 2013.

Zhang Zhan, Yang Xuejiao, Wang Yun, et al. Cytochrome P450 2A13 is an efficient enzyme in metabolic activation of aflatoxin G1 in human bronchial epithelial cells. Archives of toxicology. 2013;87:1697–1707.

Shen Haitao, Lv Ping, Xing Xin, et al. Impairment of alveolar type-II cells involved in the toxicity of Aflatoxin G(1) in rat lung. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association. 2012;50:3222–3228.

Yang Xue-Jiao J., Lu Hui-Yuan Y., Li Zi-Yin Y., et al. Cytochrome P450 2A13 mediates aflatoxin B1-induced cytotoxicity and apoptosis in human bronchial epithelial cells. Toxicology. 2012;300:138–148.

Guindon Katherine A., Foley Julie F., Maronpot Robert R., Massey Thomas E.. Failure of catalase to protect against aflatoxin B1-induced mouse lung tumorigenicity. Toxicology and applied pharmacology. 2008;227:179–183.

Guindon Katherine A., Bedard Leanne L., Massey Thomas E.. Elevation of 8-hydroxydeoxyguanosine in DNA from isolated mouse lung cells following in vivo treatment with aflatoxin B(1). Toxicological sciences : an official journal of the Society of Toxicology. 2007;98:57–62.

Van Vleet Terry R., Watterson Todd L., Klein Patrick J., Coulombe Roger A.. Aflatoxin B1 alters the expression of p53 in cytochrome P450-expressing human lung cells. Toxicological sciences : an official journal of the Society of Toxicology. 2006;89:399–407.

He Xiao-Yang Y., Tang Lili, Wang Shou-Lin L., Cai Qing-Song S., Wang Jia-Sheng S., Hong Jun-Yan Y.. Efficient activation of aflatoxin B1 by cytochrome P450 2A13, an enzyme predominantly expressed in human respiratory tract. International journal of cancer. Journal international du cancer. 2006;118:2665–2671.

Zhu Liang-Ru R., Thomas Paul E., Lu Gang, et al. CYP2A13 in human respiratory tissues and lung cancers: an immunohistochemical study with a new peptide-specific antibody. Drug metabolism and disposition: the biological fate of chemicals. 2006;34:1672–1676.

Pepeljnjak S., Slobodnjak Z., Segvić M., Peraica M., Pavlović M.. The ability of fungal isolates from human lung aspergilloma to produce mycotoxins. Human & experimental toxicology. 2004;23:15–19.

Huang Xiang-Hua H., Zhang Xiang-Hong H., Li Yue-Hong H., et al. [Experimental lung carcinogenic in vivo study of aflatoxin G1 in NIH mice]. Zhonghua bing li xue za zhi Chinese journal of pathology. 2004;33:260–263.

Larsson P., Persson E., Tydén E., Tjälve H.. Cell-specific activation of aflatoxin B1 correlates with presence of some cytochrome P450 enzymes in olfactory and respiratory tissues in horse. Research in veterinary science. 2003;74:227–233.

Tam Andrew S., Devereux Theodora R., Patel Arti C., Foley Julie F., Maronpot Robert R., Massey Thomas E.. Perturbations of the Ink4a/Arf gene locus in aflatoxin B1-induced mouse lung tumors. Carcinogenesis. 2003;24:121–132.

Van Vleet Terry R., Macé Katherine, Coulombe Roger A.. Comparative aflatoxin B(1) activation and cytotoxicity in human bronchial cells expressing cytochromes P450 1A2 and 3A4. Cancer research. 2002;62:105–112.

Van Vleet Terry R., Klein Patrick J., Coulombe Roger A.. Metabolism and cytotoxicity of aflatoxin b1 in cytochrome p-450-expressing human lung cells. Journal of toxicology and environmental health. Part A. 2002;65:853–867.

Obasi S. C.. Effects of scopoletin and aflatoxin B1 on bovine hepatic mitochondrial respiratory complexes, 2: a-ketoglutarate cytochrome c and succinate cytochrome c reductases. Zeitschrift für Naturforschung. C, Journal of biosciences. 2001;56:278–282.

Van Vleet T. R., Klein P. J., Coulombe R. A.. Metabolism of aflatoxin B1 by normal human bronchial epithelial cells. Journal of toxicology and environmental health. Part A. 2001;63:525–540.

Palanee T., Dutton M. F., Chuturgoon A. A.. Cytotoxicity of aflatoxin B1 and its chemically synthesised epoxide derivative on the A549 human epithelioid lung cell line. Mycopathologia. 2001;151:155–159.

Georggiett O. C., Muiño J. C., Montrull H., Brizuela N., Avalos S., Gómez R. M.. [Relationship between lung cancer and aflatoxin B1]. Revista de la Facultad de Ciencias Médicas (Córdoba, Argentina). 2000;57:95–107.

Massey T. E., Smith G. B., Tam A. S.. Mechanisms of aflatoxin B1 lung tumorigenesis. Experimental lung research. 2000;26:673–683.

Stewart R. K., Smith G. B., Donnelly P. J., et al. Glutathione S-transferase-catalyzed conjugation of bioactivated aflatoxin B(1) in human lung: differential cellular distribution and lack of significance of the GSTM1 genetic polymorphism. Carcinogenesis. 1999;20:1971–1977.

Tam A. S., Foley J. F., Devereux T. R., Maronpot R. R., Massey T. E.. High frequency and heterogeneous distribution of p53 mutations in aflatoxin B1-induced mouse lung tumors. Cancer research. 1999;59:3634–3640.

Donnelly P. J., Massey T. E.. Ki-ras activation in lung cells isolated from AC3F1 (A/J x C3H/HeJ) mice after treatment with aflatoxin B1. Molecular carcinogenesis. 1999;26:62–67.

Kelly J. D., Eaton D. L., Guengerich F. P., Coulombe R. A.. Aflatoxin B1 activation in human lung. Toxicology and applied pharmacology. 1997;144:88–95.

Donnelly P. J., Devereux T. R., Foley J. F., Maronpot R. R., Anderson M. W., Massey T. E.. Activation of K-ras in aflatoxin B1-induced lung tumors from AC3F1 (A/J x C3H/HeJ) mice. Carcinogenesis. 1996;17:1735–1740.

Im S. H., Bolt M. W., Stewart R. K., Massey T. E.. Modulation of aflatoxin B1 biotransformation by beta-naphthoflavone in isolated rabbit lung cells. Archives of toxicology. 1996;71:72–79.

Denning D. W., Quiepo S. C., Altman D. G., et al. Aflatoxin and outcome from acute lower respiratory infection in children in The Philippines. Annals of tropical paediatrics. 1995;15:209–216.

Lougheed M. D., Roos J. O., Waddell W. R., Munt P. W.. Desquamative interstitial pneumonitis and diffuse alveolar damage in textile workers. Potential role of mycotoxins. Chest. 1995;108:1196–1200.

Jakab G. J., Hmieleski R. R., Zarba A., Hemenway D. R., Groopman J. D.. Respiratory aflatoxicosis: suppression of pulmonary and systemic host defenses in rats and mice. Toxicology and applied pharmacology. 1994;125:198–205.

Daniels J. M., Matula T. I., Massey T. E.. DNA binding and mutagenicity of aflatoxin B1 catalyzed by isolated rabbit lung cells. Carcinogenesis. 1993;14:1429–1434.

Cusumano V.. Aflatoxins in sera from patients with lung cancer. Oncology. 1991;48:194–195.

Dvorácková I., Píchová V.. Pulmonary interstitial fibrosis with evidence of aflatoxin B1 in lung tissue. Journal of toxicology and environmental health. 1986;18:153–157.

Mulvey J. J., Rothschild H., Ciegler A., Fan Y., Marier R. L.. The association of fungi with sugarcane production and lung cancer mortality in Louisiana. The Journal of the Louisiana State Medical Society. 1983;135:3–4.

Dvorackova I., Stora C., Ayraud N.. Evidence of aflatoxin B1 in two cases of lung cancer in man. Journal of cancer research and clinical oncology. 1981;100:221–224.

Wang T. C., Cerutti P. A.. Formation and removal of aflatoxin B1-induced DNA lesions in epithelioid human lung cells. Cancer research. 1979;39:5165–5170.

Das S. K., Nair R. C., Patthey H. L., Mgbodile M. U.. The effects of aflatoxin B1 on rat fetal lung lipids. Biology of the neonate. 1978;33:283–288.

Lundborg M., Holma B.. In vitro phagocytosis of fungal spores by rabbit lung macrophages. Sabouraudia. 1972;10:152–156.

Legator M. S., Zuffante S. M., Harp A. R.. Aflatoxin: effect on cultured heteroploid human embryonic lung cells. Nature. 1965;208:345–347.